Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421276 · ClinicalTrials.gov registry record · NA
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02421276 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 45 participants.
The verdict
NCT02421276, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study plans to learn more about Down syndrome. The investigators think there is a different level of the AIRE gene in individuals with Down syndrome. The investigators think that the AIRE gene level can provide more insight about depressed immune cell function in individuals with Down syndrome. Patients are being asked to be in this research study because the investigators want to see if their blood contains more of less of the AIRE gene.
Interventions
- OTHER Phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-10-19 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421276
The ClinicalTrials.gov registry entry for NCT02421276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phlebotomy is the first listed.
NCT02421276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02421276 about?
NCT02421276 is a clinical study titled "Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome". This study plans to learn more about Down syndrome. The investigators think there is a different level of the AIRE gene in individuals with Down syndrome. The investigators think that the AIRE gene level can provide more insight about depressed immune cell function in individuals with Down syndrome....
What is the current status of trial NCT02421276?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-10-19. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02421276?
The interventions under investigation include: Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT02421276?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.